机构：[1]Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China临床科室肿瘤内科河北医科大学第四医院[2]Department of Research Center, Fourth Hospital of Hebei Medical University, Shjiazhuang, China河北医科大学第四医院科研中心医技科室[3]The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China
第一作者机构：[1]Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China
推荐引用方式(GB/T 7714)：
Shi Jian,Liu Rongfeng,Huang Guanglei,et al.The landscape of germline mutations and the relationship with tumor mutation burden in Chinese patients with lung cancer.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):
APA：
Shi, Jian,Liu, Rongfeng,Huang, Guanglei,Wang, Lixing,Shan, Baoen...&Qi, Yingxue.(2021).The landscape of germline mutations and the relationship with tumor mutation burden in Chinese patients with lung cancer..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Shi, Jian,et al."The landscape of germline mutations and the relationship with tumor mutation burden in Chinese patients with lung cancer.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)
医学